Original Article

Journal of Investigative Dermatology (1980) 74, 197–199; doi:10.1111/1523-1747.ep12541710

Potential Ocular Complications from PUVA Therapy and Their Prevention

Sidney Lerman1, Judith Megaw and Isaac Willis2

  1. 1Laboratory for Ophthalmic Research, Emory University, Atlanta, Georgia, U.S.A.
  2. 2Veterans Administration Hospital, Decatur, Georgia, U.S.A.

Received 14 May 1979; Accepted 18 October 1979.

Top

Abstract

During the last decade psoralens have become increasingly popular in treating psoriasis. The well-known photosensitizing action of these drugs has led to increasing concern regarding potential ocular complications, particularly in patients receiving prolonged psoralen therapy. We have demonstrated that this drug can be found in lenses of rats injected (intraperitoneally) with 4–8 mg/kg of 8-methoxypsoralen (8-MOP) and that its presence can lead to a photosensitized enhancement of lenticular fluorescence. Our experiments suggest one mechanism regarding the photosensitizing properties of 8-MOP within the ocular lens. Photo-addition products are generated with certain amino acid residues in the lens proteins which may result in the permanent retention of this compound within the ocular lens. We have recently shown that free 8-MOP can also be detected in human lenses for at least 12 hr following oral ingestion. Since the free 8-MOP tends to diffuse out of the lens during this period of time (as long as photic stimulation is prevented) it may be possible to prevent these photochemical reactions if the patient avoids exposure to ambient light for 12–24 hr immediately following ingestion of the drug. It may also be possible to protect these patients with special glasses which are capable of reflecting all UV radiation (up to 400 nm) while completely transmitting the visible radiation (400–750 nm).

Top

References

  1. Lerman, S: Lens proteins and fluorescence. Israel J Med Sci 1972 8: 1583–1589,  | PubMed | ChemPort |
  2. Pirie, A: Photo-oxidation of proteins and comparison of photooxidized proteins with those of the cataractous human lens. Israel J Med Sei 1972 8: 1567–1573,  | ChemPort |
  3. Pirie, A: Effect of sunlight on proteins of the lens. Contemporary Ophthalmology 1972 Edited by Bellows. Williams and Wilkins, Baltimore, p 484,
  4. van Heyningen, R: Assay of fluorescent glucosides in the human lens. Exp Eye Res 1973 15: 121–126,  | PubMed | ChemPort |
  5. van Heyningen, R: The glucoside of 3-hydroxykynurenine and other fluorescent compounds in the human lens. Ciba Symposium: The Human Lens in Relation to Cataract 1973 Elsevier, Amsterdam,
  6. Zigman, S, Schultz, JB, Yulo, T, Grover, D: Effects of near UV irradiation on lens and aqueous humor proteins. Israel J Med Sci 1972 8: 1590–1595,  | PubMed | ChemPort |
  7. Satoh, K, Bando, M, Nakajima, A: Fluorescence in human lens. Exp Eye Res 1973 16: 167–172,  | Article | PubMed | ChemPort |
  8. Augusteyn, RC: Human lens albuminoid. Jap J Ophthalmol 1974 19: 127–134,
  9. Spector, A, Roy, D, Stauffer, J: Isolation and characterization of an age-dependent polypeptide from human lens with non-tryptophan fluorescence. Exp Eye Res 1975 21: 9–24,  | Article | PubMed | ChemPort |
  10. Bando, M, Nakajima, A, Satoh, K: Coloration of human lens protein. Exp Eye Res 1975 20: 489–492,  | Article | PubMed | ChemPort |
  11. Lerman, S: Lens fluorescence in aging and cataract formation. Doc Ophthalmol Proc Series 1976 8: 241–260,  | ChemPort |
  12. Truscott, RJW, Augusteyn, RC: Changes in human lens proteins during nuclear cataract formation. Exp Eye Res 1977 24: 159–170,  | Article | PubMed | ChemPort |
  13. Lerman, S, Borkman, RF: Photochemistry and lens aging, Interdisciplinary Topics in Gerontology 1978 13: S. Karger, Basel, ed. H. P. von Hahn 1978, p 154,  | ChemPort |
  14. Van Haard, PMM, Kramps, JA, Hoenders, HJ, Wollensak, J: Development of non-disulfide covalent cross-links in nuclear cataractogenesis. Interdisciplinary Topics in Gerontology 1978 13: 212–224,  | ChemPort |
  15. Lerman, S, Kuck, JF, Borkman, R, Saker, E: Induction, acceleration and prevention (in vitro) of an aging parameter in the ocular lens. Ophthal Res 1976 8: 213–226,  | ChemPort |
  16. Zigman, S, Schultz, J, Yulo, T: Cataract induction in mice exposed to near UV light. Ophthal Res 1974 6: 259,  | ChemPort |
  17. Pitts, DG, Hacker, PD, Parr, WH: Ocular ultraviolet effects from 295 nm to 400 nm in the rabbit eye 1977 DHEW (NIOSH) Publication No. 77–175, October,
  18. Lerman, S: Ultraviolet radiation and human cataractogenesis. Invest Ophthalmol Vis Sci (Suppl) 1979 18: 128,
  19. Lerman, S: Radiant Energy and the Eye 1979 MacMillan Publishing Company, New York, chap 2
  20. El Mofty, AM: Preliminary clinical report of treatment of leucoderma with Ammi majus Linn. J R Egypt Med Assoc 1948 31: 651–665,
  21. Cloud, TM, Hakim, R, Griffin, AC: Photosensitization of the eye with methoxsalen. Arch Ophthalmol 1960 64: 346–351,  | PubMed | ChemPort |
  22. Cloud, TM, Hakim, R, Griffin, AC: Photosensitization of the eye with methoxsalen. II. Chronic effects. Arch Ophthalmol 1961 66: 689–694,  | PubMed | ChemPort |
  23. Freeman, RG: Morphologic changes resulting from photosensitization of the eye with 8-methoxypsoralen-A comparison with ultraviolet injury. Tex Rep Biol Med 1966 24: 588–596,
  24. Koch, H-R, Beitzen, R, Kremer, F, Lerman, S: Effect of 8-methoxypsoralen and long UV on the rat lens. Invest Ophthalmol Vis Sei 1979 18: 218,
  25. Parrish, JA, Fitzpatrick, TB, Tannenbaum, L, Pathak, MA: Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 1974 291: 1207–1211,  | PubMed | ISI | ChemPort |
  26. Melski, JW, Tanenbaurn, L, Parrish, JA, Fitzpatrick, TB, Bleick, HL: 28 participating investigators: Oral methoxsalen photochemotherapy for the treatment of psoriasis; A cooperative clinical trial. J Invest Dermatol 1977 68: 328–335,  | Article | PubMed | ISI | ChemPort |
  27. Pathak, MA, Stratton, K: Proceedings of the Fourth International Photobiological Congress 1965 Pergamon Press, Oxford, pp 419–440,
  28. Mantulin, WW, Song, PS: Excited states of skin-sensitizing coumarins and psoralins. Spectroscopic studies. J Am Chem Soc 1973 95: 5112–5129,
  29. Poppe, W, Grossweiner, LI: Photodynamic sensitization by 8-methoxypsoralen via the singlet oxygen mechanism. Photochem Photobiol 1975 22: 217–219,  | PubMed | ChemPort |
  30. Moore, TA, Montgomery, AB, Kwiram, AL: Triplet electronic structure and photoreactivity of 8-methoxypsoralen. Photochem Photobiol 1976 24: 83–86,  | PubMed | ChemPort |
  31. Dall'Acqua, S, Marciani, M, Zambon, F, Rodighiero, G: Kinetic analysis of the reaction (365 nm) between psoralen and DNA. Photochem Photochem Photobiol 1979 24: 489–495,
  32. Song, PS, Tapley, KJ: Photochemistry and photobiology of psoralens. Photochem Photobiol 1979 29: 1177–1197,  | PubMed | ChemPort |
  33. Jose, JG: The role of DNA damage, its repair and its misrepair in the etiology of a cataract: A review. Ophthal Res 1978 10: 52–62,  | ChemPort |
  34. Mizuno, N, Tsuneishi, S, Matsuhashi, S, Kimura, Fuzimura, Y, Ushizama, T: Sunlight and Man 1974 Edited by TB Fitzpatrick et al. University of Tokyo Press, Tokyo, pp 389–409,
  35. Bensasson, RV, Land, EJ, Salt, C: Triplet excited state of furocoumarins: Reaction with nucleic acid bases and amino acids. Photochem Photobiol 1978 27: 273–280,  | PubMed | ChemPort |
  36. Lerman, S, Borkman, RF: A method for detecting 8-methoxypsoralen in the ocular lens. Science 1977 197: 1287–1288,  | PubMed | ChemPort |
  37. Lerman, S, Jocoy, M, Borkman, RF: Photosensitization of the lens by 8-methoxypsoralen. Invest Ophthalmol Vis Sei 1977 16: 1065–1068,  | ChemPort |
  38. Borkman, RF, Lerman, S: Evidence for a free radical mechanism in aging and UV irradiated ocular lenses. Exp Eye Res 1977 25: 303–309,  | Article | PubMed | ChemPort |
  39. Lerman, S, Megaw, J, Borkman, RF, Willis, I: Studies on the photoreaction of 8-methoxypsoralen with tryptophan and lens proteins. Photochem Photobiol 1980 in press
  40. Wulf, HC, Hart, J: Accumulation of 8-methoxypsoralen in the rat retina. Acta Ophthalmol 1978 56: 284–290,  | ChemPort |

Extra navigation

.
ADVERTISEMENT